Colossal Biosciences, the biotech company behind plans to try to bring back the woolly mammoth, Tasmanian tiger and the dodo, raised another $200 million for its research.

Co-founded by geneticist George Church and billionaire tech entrepreneur Ben Lamm, Colossal has achieved "decacorn" status in just three years, boasting a valuation exceeding $10 billion. This rise ...

Colossal Biosciences is now valued at over $10 billion and is working on ambitious projects to resurrect multiple long ...

The Tasmanian tiger ... "Many people, however, believe that bounty hunting alone could not have driven the thylacine extinct and therefore claim that an unknown disease epidemic must have been ...

The US company, which is aiming to bring back extinct species, says that it expects its first woolly mammoth calves will be born in the next three years.

The World Economic Forum predicts that biodiversity loss could cause a colossal decline in global GDP of $2.7 trillion ...

Colossal Biosciences wants to bring back the woolly mammoth and has raised $200 million at a $10.2 billion valuation to do it.